Dec 12, 2022, 18:11 by

International Organization for Standardization publishes revisions to ISO 15189.

Dec 9, 2022, 10:51 by

Dec 8, 2022, 10:08 by

PHASTAR Joins Oncology Development Programme (ODP2) to Accelerate Development of Novel Cancer Innovations London, UK and Durham, NC – 08 December, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO), has joined Lean Life Science’s Oncology Development Programme (ODP2). The targeted programme aims to identify and accelerate novel oncology innovations into commercially-attractive assets by offering support to academics and early-stage companies.

Dec 8, 2022, 10:05 by

Partnership seeks to increase clinical trials access, accelerate recruitment, and advance ophthalmic research

Dec 8, 2022, 01:00 by User Not Found

Clinical Research News | Finalists have been named for the 7th Annual Participant Engagement Award. Winners will be announced after a live presentation and judging session at the Summit for Clinical Ops Executives. This year’s SCOPE Summit will be held February 6-9, 2023, in Orlando, Fla.

Dec 7, 2022, 09:54 by

PHASTAR, a global specialist biometrics contract research organization (CRO), has announced the launch of a pro-bono scheme to give charities access to its volunteer statisticians, data scientists, data managers and programmers at no cost.

Dec 7, 2022, 09:53 by

Global contract development and manufacturing organization (CDMO) Recipharm, today announced an extension of the ongoing commercial manufacturing of RedHill Biopharma’s (Nasdaq: RDHL) drug, Talicia® for the treatment of H. pylori infection, to 2026.

Dec 6, 2022, 11:36 by

Graegis Pharmaceuticals has announced its plan to start proof-of-concept clinical trials in 2023 in the prevention of radiation-induced dermatitis and mucositis.

Dec 6, 2022, 11:35 by

IDDI appoints new CEO, to strengthen the organization's position to support and serve US and EU clients.

Dec 6, 2022, 11:35 by

Dec 6, 2022, 01:00 by User Not Found

Clinical Research News | In the latest episode of the Scope of Things podcast, host Deborah Borfitz speaks with Dr. Arturo Loaiza-Bonilla, co-founder and chief medical officer of Massive Bio, about increasing clinical trial access for cancer patients and offering next-generation enrollment services.

Dec 5, 2022, 10:52 by

MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, has awarded a $100,000 research grant to Andy Livingston, M.D., a clinician and researcher in Sarcoma Medical Oncology and in Pediatric Oncology at The University of Texas MD Anderson Cancer Center. Ann Graham, Founder and Executive Director of MIB Agents, and Christina Ip-Toma, MIB Agents’ Director of Scientific Programs, presented the award to Dr. Livingston on Dec. 1 in Houston.

Dec 1, 2022, 10:17 by

The Mobile Health/Central Lab Interface, an opportunity for DCT efficiency How streamlining relations between central labs and mobile health providers can get the most from hybrid and decentralised clinical trials

Dec 1, 2022, 10:16 by

Quotient Sciences, a global drug development and manufacturing accelerator, today announced a partnership with Emplicure, a Swedish pharmaceutical company focused on chronic pain and abuse-deterrent formulations.

Dec 1, 2022, 10:16 by

The NHS could save up to £360M per year by using FFP3 face masks and the NHS already has a large stockpile of these masks so there is no current need to purchase more. Independent studies commissioned by PPE manufacturer Globus Group and carried out by York Economic Health Consortium and Vital Economics confirm that these masks may be better at preventing respiratory infection and resulting staff days off.

Dec 1, 2022, 10:12 by

Scipio bioscience has announced a grant program for researchers to receive a complete 3′ scRNA-seq solution valued at up to US$30,000.

Dec 1, 2022, 09:52 by

Dec 1, 2022, 09:51 by

Dec 1, 2022, 09:50 by

Dec 1, 2022, 09:50 by